FDA Approves Wellcovorin for Cerebral Folate Deficiency

Sat, 14 Mar 2026 15:49:42 +0000
Healthcare

The FDA has approved Wellcovorin (leucovorin calcium) tablets for the treatment of cerebral folate deficiency in adult and pediatric patients with a confirmed FOLR1 gene variant. This marks the first FDA-approved treatment for this rare genetic condition.